In the second half of the 1990s, a global trend
stimulant misuse (cocaine, amphetamine, methamphetamine,
methylenedioxymethamphetamine/MDMA, cathinone derivatives,
benzylpiperazine/BZP, etc.) was observed across a number
of EU countries.
When reorganising statutory and non-statutory services to
cope with this increasingly widespread clinical issue, the
epidemiological approach is of paramount importance, and a clear
appreciation of the levels of stimulant misuse is necessary in
order to allocate the appropriate levels of resources.
Stimulant misuse is typically associated with an imbalance of
neurotransmitters, especially dopamine. Therefore, practising
psychiatrists need to be aware of the psychopathological
consequences related to substance misuse in order to refine
their own diagnostic and clinical management skills.
Related Advances articles
Download take-home notes to print and